Gonzalo Mena-Rejón, Yussel Pérez-Navarro, Julio César Torres-Romero, Laura Vázquez-Carrillo, Rubén M Carballo, Rodrigo Arreola, Ángel Herrera-España, Victor Arana-Argáez, Ramiro Quijano-Quiñones, Jose Manuel Fernández-Sánchez, María Elizbeth Alvarez-Sánchez
Trichomoniasis, caused by the protozoan Trichomonas vaginalis, is the most prevalent non-viral sexually transmitted infection that affects over 170 million people worldwide. The only type of drug recommended for the therapeutic control of trichomoniasis is the 5-nitroimidazoles, although there have been reports of some undesirable side effects and clinical resistance. Hence, the need for the search for new tricomonicidal agents is necessary. In a previous work, we demonstrated that two 2-amino-4-aryl thiazole derivatives (ATZ-1 and ATZ-2) possess a portent antigiardial effect...
October 19, 2020: Parasitology Research